Drug companies abandon psychiatry

Did you know that many major drug companies have either ceased their involvement in psychiatric research altogether or considerably reduced their involvement?

This is not a development that reflects well on psychiatry, which is why it has received so little publicity.

But it is a profoundly significant development, for a number of reasons. Not many years ago, psychiatry and the pharmaceutical industry were cosy bedfellows, “partners”.

Not any more.

I wrote about this development, why it has happened, and its major significance, in my 2015 book Depression Delusion: The Myth of the Brain Chemical Imbalance, foreword by Robert Whitaker.

To receive a free extract about this major development, subscribe to my newsletter updates through the form at the end of this blog. You can unsubscribe any time you like.

Best wishes,

Terry.

Dr. Terry Lynch.

Physician; psychotherapist; best-selling mental health author; provider of recovery-oriented mental health service; member of Expert Group on Mental Health Policy (2003-6) that formulated A Vision for Change, Ireland’s official mental health policy document.

 

Join the newsletter and receive free pdf, "Drug companies abandon psychiatry"

Subscribe to get our latest content by email.

Success! Now check your email to confirm your subscription.

There was an error submitting your subscription. Please try again.

First Name

Email Address

We use this field to detect spam bots. If you fill this in, you will be marked as a spammer.

Subscribe Powered by Kit

Share